ATI RN
ATI Pharmacology Across the Lifespan Questions
Question 1 of 5
A pregnant patient recently began treatment for hypothyroidism. What response will the provider give when the patient shares that she does not want to take medications while she is pregnant?
Correct Answer: A
Rationale: The correct answer is A because untreated hypothyroidism during pregnancy can lead to permanent neuropsychologic deficits in the baby. Thyroid hormones are crucial for fetal brain development. If the mother's thyroid levels are not adequately controlled, it can impact the baby's cognitive and neurological development. Choice B is incorrect as hypothyroidism is not a normal effect of pregnancy and can have serious consequences if left untreated. Choice C is incorrect as treatment for hypothyroidism is essential during pregnancy regardless of symptoms to prevent complications for both the mother and the baby. Choice D is incorrect as the danger to the fetus exists throughout the pregnancy, not just in the third trimester.
Question 2 of 5
What mechanism of action or pharmacological action is best associated with pramlintide (Symlin)?
Correct Answer: D
Rationale: The correct answer is D: Synthetic amylin analog. Pramlintide is a synthetic analog of amylin, a hormone co-secreted with insulin. It works by mimicking the action of natural amylin to regulate glucose levels, slow gastric emptying, and suppress postprandial glucagon secretion. This helps to reduce postprandial blood sugar spikes in patients with diabetes. Choice A is incorrect because pramlintide does not have any impact on the renin-angiotensin-aldosterone system. Choice B is incorrect as pramlintide does not block glycine and GABA release. Choice C is incorrect as pramlintide is not an NMDA receptor antagonist. Overall, the correct answer is D because pramlintide's mechanism of action closely resembles that of natural amylin.
Question 3 of 5
The pharmacological properties of which one of the following medications is similar to Amphetamine?
Correct Answer: A
Rationale: The correct answer is A: Methylphenidate. Methylphenidate is a central nervous system stimulant, like amphetamine, used to treat ADHD. Both drugs increase dopamine and norepinephrine levels in the brain. Atomoxetine (B) is a non-stimulant used for ADHD. Lithium (C) is used for bipolar disorder and does not have stimulant properties. Haldol (D) is an antipsychotic medication with different mechanisms of action.
Question 4 of 5
A patient developed hives and itching after receiving a drug for the first time. Which instruction by the nurse is accurate?
Correct Answer: A
Rationale: Step-by-step rationale for why choice A is correct: 1. Stopping the medication is crucial to prevent further allergic reactions. 2. Encouraging the patient to wear a medical alert bracelet will help healthcare providers quickly identify the allergy. 3. This action promotes patient safety and prevents future adverse reactions. Summary of why the other choices are incorrect: B: Anaphylactic reactions are severe and life-threatening, and hives and itching do not necessarily indicate an anaphylactic reaction. C: Lowering the dosage is not the appropriate response to an allergic reaction; stopping the medication is necessary. D: It is not safe to assume that the reaction was mild, as allergic reactions can escalate upon subsequent exposures.
Question 5 of 5
A patient receives 200 mg of a medication that has a half-life of 12 hours. How many mg of the drug would remain in the patient's body after 24 hours? _____
Correct Answer: A
Rationale: Rationale: After 24 hours, two half-lives of the medication have passed. Initially, 200 mg is halved to 100 mg after 12 hours (1st half-life), then halved again to 50 mg after another 12 hours (2nd half-life). Therefore, only 50 mg of the drug would remain after 24 hours. Summary of other choices: - B: 100 mg - Incorrect, this is the amount remaining after the first half-life, not after 24 hours. - C: 150 mg - Incorrect, this is not the correct calculation based on the drug's half-life. - D: 200 mg - Incorrect, the drug undergoes degradation over time due to its half-life, so the amount remaining after 24 hours is less than the initial dose of 200 mg.